CIS Insulin Market Poised To Augment The Industry At $ 3,008.5 Million By 2020 : Grand View Research Inc.
San Francisco, 13 September 2019: The Report CIS Insulin Market (Rapid Acting, Short Acting, Pre-Mixed, Long Acting, Type I & II Diabetes, Analogs, Recombinant Insulin) Analysis And Segment Forecasts To 2020 The CIS Insulin Market is expected to reach USD 3,008.5 million by 2020 growing at a CAGR of 15.0%, according to a new study by Grand View Research, Inc. The presence of an extensive pipeline portfolio of products exhibiting higher efficacies and their subsequent commercialization over the next six years is expected to serve this market as a high impact rendering driver. The introduction of government initiatives aimed at improving the affordability of insulin via price reduction, such as the collaboration between the government of Ukraine and Indar to reduce the price of insulin by 20% in 2013 is expected to have positive influence on demand. Some of the other drivers of this market include increasing attempts made by manufacturers to c...